Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Published April 22, 2026 · Recall initiated: April 8, 2026
Summary
FDA records drug Class II recall D-0510-2026, published April 22, 2026 and initiated April 8, 2026. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: VM4231, Exp 06/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if DESMOPRESSIN ACETATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DESMOPRESSIN ACETATE
- Manufacturer
- Apotex Corp.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: VM4231, Exp 06/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMagnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), AvantorApril 22, 2026
- FDALidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: HuonsApril 22, 2026
- FDABlemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6April 22, 2026
- FDABupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only,April 22, 2026
- FDAMemantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only,April 22, 2026
- FDADesmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. EastDecember 7, 2022
Questions about this recall
Was Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0 recalled?
Yes. FDA published recall D-0510-2026 on April 22, 2026. Reported hazard: Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DESMOPRESSIN ACETATE.